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Background: Clindamycin has been a good alternative drug to penicillins in the treatment of infections caused 
by Staphylococcus aureus but resistance to this agent has led to therapeutic failure. Inducible clindamycin 
resistance in staphylococci carrying erm genes may not be detectable by routine disk diffusion test. The 
objective of this study is to phenotypically detect clindamycin resistance in clinical S. aureus isolates and 
determine the prevalence of ermA, ermB and ermC carriage among these isolates. 
Methodology: A total of 230 non-duplicate S. aureus were isolated from children admitted to 
Mansoura University Children Hospital during the period January 2016 and June 2017 by 
conventional microbiology method. Invitro antibiotic susceptibility to selected antibiotics including 
erythromycin was performed by the disk diffusion technique. The „D-zone‟ test was used to 
phenotypically detect inducible clindamycin resistance. The presence of ermA, ermB and ermC 
genes was confirmed by multiplex polymerase chain reaction (m-PCR) assay.                  
Results: One hundred and seven (46.6%) isolates were phenotypically resistant to erythromycin 
while 109 (47.3%) were methicillin (cefoxitin) resistant S. aureus (MRSA). The macrolide-
lincosamin-streptograminB (MLSB) phenotypes among the erythromycin resistant isolates were 47 
(44%) inducible MLSB and 46 (43%) constitutive MLSB, while 14 (13.0%) were MS phenotype. 
Although, the MLSB phenotype was more predominant in MRSA (n=60, 56.1%) than MSSA (n=33, 
30.7%) while the MS phenotype was more predominant in MSSA (n=9, 8.4%) than MRSA (n=5, 
4.6%) isolates, the difference was not statistically significant (p=0.0777). The ermA (29.0%, n=31) 
and ermC (18.7%, n=20) were the most prevalent genes carried by the isolates while ermB was 
carried by a few (4.7%, n=5). Forty six (43%) isolates did not carry any detectable erm gene.       
Conclusion: In this study, both inducible and constitutive clindamycin resistance phenotypes were 
common among S. aureus isolates. Although the genetic basis for this may be attributed to carriage 
of ermA, ermB and ermC genes, a number of the resistant isolates did not carry any of these genes. 
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Abstrait:                      
 
Contexte: La clindamycine était un bon médicament alternatif aux pénicillines dans le traitement des 
infections causées par Staphylococcus aureus, mais la résistance à cet agent a entraîné un échec 
thérapeutique. La résistance inductible à la clindamycine chez les staphylocoques porteurs du gène erm peut 
ne pas être détectable par le test de diffusion systématique sur disque. L'objectif de cette étude est de détecter 
phénotypiquement la résistance à la clindamycine dans les isolats cliniques de S. aureus et de déterminer la 
prévalence du portage d'ermA, d'ermB et d'ermC parmi ces isolats.                             Méthodologie: Un total de 230 S. aureus non dupliqués ont été isolés parmi les enfants admis à l'hôpital universitaire de Mansoura entre janvier 2016 et juin 2017 par la méthode de microbiologie conventionnelle. La sensibilité in vitro des antibiotiques à une 
sélection d‟antibiotiques, notamment à l‟érythromycine, a été réalisée par la technique de diffusion sur disque. 
Le test de la «zone D» a été utilisé pour détecter phénotypiquement la résistance inductible à la clindamycine. 
La présence des gènes ermA, ermB et ermC a été confirmée par un test de réaction en chaîne de la 
polymérase multiplexe (m-PCR). 
Résultats: Cent sept isolats (46,6%) étaient phénotypiquement résistants à l'érythromycine, tandis que 109 
(47,3%) étaient résistants à la méthicilline (céfoxitine) S. aureus (MRSA). Les phénotypes macrolide-
lincosamin-streptogramine B (MLSB) parmi les isolats résistants à l'érythromycine étaient 47 (44%) MLSB 
inductibles et 46 (43%) MLSB constitutifs, alors que 14 (13,0%) étaient des phénotypes MS. Bien que le 
phénotype MLSB soit plus prédominant dans le SARM (n=60, 56,1%) que le MSSA (n=33, 30,7%), le 
phénotype MS était plus prédominant dans le MSSA (n=9, 8,4%) que le SARM (n=5, 4,6%), la différence 
n'était pas statistiquement significative (p=0,0777). ErmA (29,0%, n=31) et ermC (18,7%, n=20) étaient les 
gènes les plus prévalents portés par les isolats, tandis que ermB était porté par quelques-uns (4,7%, n=5). 
Quarante-six (43%) isolats ne portaient aucun erm gène détectable. 
Conclusion: Dans cette étude, les phénotypes de résistance à la clindamycine tant inductibles que constitutifs 
étaient courants parmi les isolats de S. aureus. Bien que la base génétique de ceci puisse être attribuée au 
portage des gènes ermA, ermB et ermC, un certain nombre des isolats résistants ne portaient aucun de ces 
gènes. 
 




 Staphylococcus aureus is a 
common bacterial pathogen responsible for 
both community and hospital acquired 
infections. The infection caused by S. aureus 
ranges from mild skin and soft tissue to life 
threatening infections such as septicemia, 
meningitis and endocarditis (1). The major 
concern about this pathogen is its ability to 
acquire resistance to multiple antibiotics. 
Resistance to penicillin and methicillin has led 
to the use of alternative antibiotics especially 
macrolides and lincosamides such as 
clindamycin. Clindamycin can be given both 
orally and intravenously and it is effective 
against soft tissue infections as well as deep 
penetrating infections such as sepsis (2).                                                                                  
 Resistance to clindamycin is 
usually associated with macrolides resistance 
especially erythromycin (3-7). The respon- 
sible mechanisms for macrolide and 
clindamycin resistance are attributed to two 
mechanisms (8). The first mechanism is due 
to the efflux of antibiotics outside the 
bacterial cell wall before its binding to 
ribosome. This mechanism is commonly 
reported in S. aureus and is controlled by 
msrA gene (9). The other mechanism is 
called MLSB (macrolide, lincosamide, 
streptogramin B) which is due to changes on 
the ribosome affecting the binding site as a 
result of methylation of the 23S rRNA–
binding site of macrolides. This results in 
resistance to macrolides and is controlled by 
the ermA, ermB and ermC genes (8, 9). 
 Clindamycin resistance can be 
detected phenotypically by two methods. The 
first method detects constitutive clindamycin 
resistance (cMLSB) phenotype by the disk 
diffusion technique. The other method called 
the “D-zone” test detects inducible 
clindamycin resistance (iMLSB) in susceptible 
isolates by adding erythromycin (which is a 
known strong methylase inducer in 
susceptible strains) to clindamycin disks, 
which results in appearance of a blunting of 
the clindamycin inhibition zone (appearing 
like a letter D) on the margin closest to the 
erythromycin disk (10).  
 Published data on the presence of S. 
aureus strains resistant to clindamycin in 
Egypt are lacking, however, information on 
this could have important implications for 
treatment protocols against staphylococcal 
infections in the country. The aim of this 
research therefore is to determine the 
carriage rate of erm genes responsible for 
inducible clindamycin resistance among 
clinical S. aureus isolates in Egypt.  
 
Materials and method: 
Study design and subjects  
 This cross sectional study was 
conducted on randomly selected children 
admitted to Mansoura University Children 
Hospital, Egypt, between January 2016 and 
June 2017, from whom 230 non-repetitive S. 
aureus isolates were obtained. The study was 
approved by Mansoura Faculty of Medicine 
Institutional Ethical Committee 
Specimen collection   
 The samples for S. aureus isolation 
were from various clinical specimens such as 




blood cultures (n=157), wound samples 
(n=41), and broncho alveolar lavage (n=32). 
Isolation and identification of S. aureus
 All specimens were inoculated on 
Sheep blood and MacConkey agar plates, and 
incubated at 37°C aerobically for 24 hours. 
Identification of S. aureus was first done by 
colony morphology on plates, followed by 
conventional identification methods of Gram 
stain, catalase activity, and slide and tube 
coagulase tests.  
Antibiotic susceptibility test  
 Antibiotic susceptibility test (AST) 
was performed on all identified S. aureus 
isolates (n=230) in accordance with the 
Clinical and Laboratory Standards Institute 
(CLSI) agar disk diffusion method on Mueller-
Hinton (MH) agar (11) with the following 
disks (Oxoid, England); erythromycin (15μg), 
ampicillin-sulbactam (20 μg / 20 µg), 
amoxicillin-clavulanic acid (20 μg / 10 μg), 
piperacillin (30µg), ciprofloxacin (5μg), 
ceftriaxone (5µg), cephradine (30µg), 
cefotaxime (30μg), ceftazidime (30µg), and 
cefoperazone (75µg).  
Detection of methicillin resistance  
 Methicillin resistance was detected by 
the cefoxitin (30μg) disk diffusion test on MH 
plates which were inoculated with the 
standardized inoculum of the S. aureus 
isolates (n=230), and incubated at 37°C for 
24 hours. S. aureus with cefoxitin inhibition 
zone ≤ 21mm were considered MRSA (10).  
Detection of clindamycin resistance 
 All S. aureus isolates resistant to 
erythromycin in the AST (n=107) were 
evaluated for clindamycin resistance by the 
disk diffusion method as previously described 
(10). The isolated colonies were diluted in 
sterile normal saline to obtain 0.5 
McFarland‟s standard suspension. The 
inoculum was aseptically plated over MH agar 
plate, with both erythromycin (15μg) and 
clindamycin (2μg) disks placed ~15 mm 
apart edge to edge, and incubated 
aerobically   at  37oC  for  24 hours.  Isolates 
resistant to erythromycin (zone of inhibition 
<13mm) with flattening of zone (D-zone) 
around the clindamycin disk (zone of 
inhibition≥21mm) were identified as 
inducible resistance phenotype (Fig 1). 
 Isolates resistant to both 
erythromycin and clindamycin (zone of 
inhibition<21mm) were identified as 
constitutive resistance phenotype (cMLSB) 
and isolates resistant to erythromycin but 
susceptible to clindamycin (zone of inhibition 
≥21mm) with no D-zone were identified as 
MS phenotype (10).  
Multiplex PCR for macrolide genes: 
 DNA extraction of purified colonies of 
all S. aureus resistant to erythromycin in the 
AST (n=107) was done by Qiagen extraction 
kit and kept frozen at -20oC until use. 
Multiplex PCR was performed for the isolates 
for detection of ermA, ermB and ermC genes 
using primers with sequences as shown in 
Table 1 (9). Amplification was performed in a 
25μL PCR mixture (Qiagen) with the use of 
50ng DNA template, and 25 pmol/L each, of 
forward and reverse primers. Thermal cycling 
was performed as follows; 5 min at 94°C, 
then 1min at 95°C, 30 sec at annealing temp 
of 55°C, and 1min at 72oC for 30 cycles, with 
a final extension at 72oC for 5min.   
 Ten μL of PCR product was resolved 
on 2% agarose gel containing 0.5mg/mL 
ethidium bromide at 90V for 1h and 
visualized in a gel documentation system. 
The reaction mix containing all materials 
except DNA was used as negative control.  
 
Fig 1: Mueller Hinton agar plate showing positive D-zone 
test in a Staphylococcus aureus isolate with inducible                      
MLSB phenotype 
Table 1: Genes and the primers sequences used in the study 
Target gene Primer sequence Product size, bp Reference 
ermA F 5´-TAT CTT ATC GTT GAG AAG GGA TT-3 




F 5´-CTA TCT GAT TGT TGA AGA AGG ATT-3´ 
R 5´-GTT TAC TCT TGG TTT AGG ATG AAA-3´ 
142 8 
ermC F 5´-CTT GTT GAT CAC GAT AAT TTC C-3´ 









Results:     
 A total of 230 non-repetitive S. 
aureus were isolated from the subjects, 
mainly from blood cultures (n=157, 68.4%), 
wound samples (n=41, 17.9%) and broncho- 
alveolar lavage (n=32, 13.7%). All isolates 
were resistant to the tested antibiotics to 
varying degrees, with 109 resistant to 
cefoxitin, representing MRSA rate of 47.3%, 
and 107 (46.6%) resistant to erythromycin 
(Table 2).   
Table 2: Invitro antibiotic resistance of Staphylococcus 
aureus in Mansoura University Children Hospital, Egypt 
 
 The result of the D-zone test shows 
that 93 of the 107 (86.9%) erythromycin 
resistant S. aureus isolates were MLSB 
phenotype (iMLSB, 43.9% and cMLSB, 
43.0%) while 14 (13.1%) were MS 
phenotype (Table 3).    
     
    
 Although, the MLSB phenotype was 
more predominant in MRSA (n=60, 56.1%) 
than MSSA (n=33, 30.8%) while the MS 
phenotype was more predominant in MSSA 
(n=9, 8.4%) than MRSA (n=5, 4.7%) 
isolates, the difference was not statistically 
significant (X2 = 3.112, p = 0.0777).  
 Table 4 shows the carriage rates of 
erm genes among the 107 erythromycin 
resistant S. aureus isolates, with ermA 
(29.0%, n=31), ermC (18.7%, n=20) and 
ermB (4.6%, n=5). One isolate (1.0%) 
carried both ermA and ermC genes while 4 
(3.7%) isolates each carried ermA, ermB and 
ermC genes. A total of 46 (43.0%) isolates 
did not contain any of the erm genes. Fig 2 
shows gel electrophoresis of isolates with 
amplified ermA and ermC genes, and others 
with no amplified gene product.   
Table 4: Frequency of erm genes in phenotypic              
macrolide resistant Staphylococcus aureus isolates in 
Mansoura University Children Hospital, Egypt 
 
 
Table 3: Distribution of macrolide resistance phenotypes among Staphylococcus aureus isolates in Mansoura 
University Children Hospital, Egypt  
Ery-R = erythromycin resistant; CLI-S = clindamycin sensitive; MRSA = methicillin resistant Staphylococcus aureus; MSSA= 
methicillin sensitive Staphylococcus aureus; MLSB = macrolide-lincosamide-streptograminB  
p value X2 Total (%) Staphylococcus aureus isolates  Macrolide resistance 
phenotype 
MSSA (%) MRSA (%) 
0.0777 3.112 47 (43.9) 20 (18.7) 27 (25.2) Inducible  MLSB 
46 (43.0) 13 (12.2) 33 (30.8) Constitutive  MLSB 
93 (86.9) 33 (30.8) 60 (56.1) Sub-Total 
14 (13.1) 9 (8.4) 5 (4.7) MS (ERY-R/CLI-S) 
  107 (100) 42 (39.2) 65 (60.8) Total 
 
Antibiotic disk Frequency of 
resistance (%) 
Ciprofloxacin 64 (27.8) 
Ceftazidime 44 (19.1) 
Ceftriaxone 62 (26.9) 
Ampicillin/Sulbactam 62 (26.9) 
Cefoperazone 38| (16.3) 
Cefotaxime 52 (22.6) 
Cephradine 56 (24.3) 
Piperacillin 32 (13.9) 
Amoxicillin/Clavulanic acid 120 (52.1) 
Erythromycin 107 (46.6) 





ermB 5 (4.6) 
ermC 20 (18.7) 
ermA/ermC 1 (1.0) 
ermA/ermB/ermC 4 (3.7) 
No gene 46 (43.0) 
Total 107 






0 = molecular weight marker; 1 = isolate with amplified ermA gene; 2 & 5 = isolates with amplified ermC gene; 3 & 4 = isolate with no gene amplified 




 The prevalence of MRSA has been 
increasing worldwide since last decades. This 
prevalence varies widely across different 
countries and also in hospitals of same 
country. In this study, isolated S. aureus 
strains showed high resistance to cefoxitin, 
representing MRSA rate of 47.3%, compared 
to a lower rate of 24% previously reported in 
a study from Minia, Egypt. However various 
studies have reported MRSA rate ranging 
from 50% to 68% (10,12,13).   
 There was also relatively high 
resistance to other beta lactam antibiotics 
such as ampicillin-sulbactam (26.9%), 
amoxicillin-clavulanic acid (52.1%), pipera- 
cillin (13.9%), ceftriaxone (26.9%), cefta- 
zidime (19.1%), cefotaxime (22.6%), ceph- 
radine (24.3%), and cefoperazone (16.3%) 
in this study. This multidrug resistance 
among S. aureus can be explained by the 
common association of mecA (methicillin 
gene) with other resistant genes for beta 
lactamase production, leading to cross 
resistance to other beta lactam antibiotics. 
Previous studies have shown such association 
(14, 15).  
 Phenotypic resistance to erythro- 
mycin was 46.6% in this study. Similar rates 
of resistance to erythromycin were reported 
previously ranging from 46% to 51.7% (16-
18) whereas lower rates ranging from 15.7% 
to 28.4% were reported by others (19,20). 
The MRSA isolates is our study had higher 
rate for both inducible MLSB (25.2%) and 
constitive MLSB (30.8%) phenotypes than    
the    MSSA    isolates    (though   not statis- 
tically significant), which agrees with the 
study of Prabhu et al., who reported 16.6% 
cMLSB phenotype in MRSA and 6.2% in MSSA 
(10). Also Gupta et al., reported cMLSB 
phenotype in 19% of the total isolates of 
which 46% were MRSA and 10% were MSSA 
(8). The phenotype of MLSB (either 
constitutive or inducible) may show great 
variations based on the patient groups in 
different hospitals and geographical regions. 
This variation may be attributed to several 
factors such as usage rate of macrolide 
antibiotics in different hospitals, age of 
patients, and source of tested isolates (15).  
 Clindamycin resistance is usually 
attributed to the carriage of any of ermA, 
ermB or ermC genes. The association of 
MRSA with clindamycin resistance can be 
attributed to acquisition of one of these 
genes via transposition to become part of the 
SCCmec cassette chromosomes containing 
the methicillin resistant (mecA) genes (16). 
In our study, ermA and ermC genes were the 
two genes frequently carried by the S. 
aureus isolates, while a few isolate carried 
the ermB gene. This is similar to the report 
of a study in Denmark over a 30 year period 
(1959–1988) by Westh et al., which showed 
high carriage rates of ermA and ermC genes 
among the S. aureus isolates but no ermB 
gene detected (21). Similarly, a multicenter 
study of 24 European University Hospitals in 
the year 2000 reported high prevalence of 
ermA (64.0%)  and  low  prevalence of ermC  




(19.5%) but much lower prevalence of ermB 
(0.6%) genes among 851 S. aureus isolates 
(22). A more recent study on animal 
staphylococci showed a similar pattern with 
carriage rate of 55.6% ermA, 30.6% ermC 
and 11.1% ermB genes (23). These are 




 From this study, we can conclude 
that clindamycin resistance is common 
among S. aureus isolates in Mansoura 
Children University Hospital, Egypt both 
inducible and constitutive types carrying 
mostly ermA and ermC genes that may be 
partly responsible for these phenotypes. 
Although, we did not find statistically 
significant association of clindamycin with 
methicillin resistance, nevertheless, we 
recommend routine mandatory testing of all 
S. aureus isolates for inducible clindamycin 
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